105129-60-0

Upstream product

• 137-07-5 2-amino-benzenethiol 
• 672-13-9 2-hydroxy-5-methoxybenzaldehyde 
• 108-24-7 acetic anhydride 
• 41570-02-9 2-(2,3-dihydrobenzo[d]thiazol-2-yl)-4-methoxyphenol 

Downstream Products

• 99320-58-8 3-acetyl-2-<2-(4-bromobutoxy)-5-methoxyphenyl>benzothiazoline 
• 93265-04-4 3-acetyl-2-[2-(4-chlorobutoxy)-5-methoxyphenyl]benzothiazoline 
• 93264-85-8 1-{2-[2-(3-Chloro-propoxy)-5-methoxy-phenyl]-benzothiazol-3-yl}-ethanone 
• 86135-29-7 1-(2-{2-[6-(Cyclohexyl-methyl-amino)-hexyloxy]-5-methoxy-phenyl}-benzothiazol-3-yl)-ethanone 
• 86135-88-8 1-{2-[2-(6-{4-[2-(3,4-Dimethoxy-phenyl)-ethyl]-piperazin-1-yl}-hexyloxy)-5-methoxy-phenyl]-benzothiazol-3-yl}-ethanone 
• 86136-61-0 3-Acetyl-2-[2-[4-[4-[2-(3,4,5-trimethoxyphenyl)ethyl]-piperazinyl]butoxy]-5-methoxyphenyl]benzothiazoline 
• 86135-86-6 1-{2-[2-(5-{4-[2-(3,4-Dimethoxy-phenyl)-ethyl]-piperazin-1-yl}-pentyloxy)-5-methoxy-phenyl]-benzothiazol-3-yl}-ethanone 
• 86135-84-4 3-Acetyl-2-[2-[4-[4-[2-(3,4-dimethoxyphenyl)ethyl]piperazinyl]-butoxy]-5-methoxyphenyl]benzothiazoline 
• 112947-21-4 1-{2-[2-(4-{Cyclopropyl-[2-(3,4,5-trimethoxy-phenyl)-ethyl]-amino}-butoxy)-5-methoxy-phenyl]-benzothiazol-3-yl}-ethanone 
• 112947-16-7 1-{2-[5-Methoxy-2-(5-{methyl-[2-(2,3,4-trimethoxy-phenyl)-ethyl]-amino}-pentyloxy)-phenyl]-benzothiazol-3-yl}-ethanone 
• 112947-22-5 1-{2-[5-Methoxy-2-(4-{methyl-[3-(2,3,4-trimethoxy-phenyl)-propyl]-amino}-butoxy)-phenyl]-benzothiazol-3-yl}-ethanone 
• 112947-20-3 1-{2-[2-(4-{Isopropyl-[2-(3,4,5-trimethoxy-phenyl)-ethyl]-amino}-butoxy)-5-methoxy-phenyl]-benzothiazol-3-yl}-ethanone 
• 86135-82-2 1-{2-[2-(3-{4-[2-(3,4-Dimethoxy-phenyl)-ethyl]-piperazin-1-yl}-propoxy)-5-methoxy-phenyl]-benzothiazol-3-yl}-ethanone 
• 112947-15-6 1-{2-[5-Methoxy-2-(4-{methyl-[2-(2,3,4-trimethoxy-phenyl)-ethyl]-amino}-butoxy)-phenyl]-benzothiazol-3-yl}-ethanone 

Relevant academic research and scientific papers

KAPPA-OPIOID RECEPTOR AGONIST COMPRISING 2-PHENYLBENZOTHIAZOLINE DERIVATIVE

The present invention provides κ opioid receptor agonists comprising 2-phenylbenzothiazoline derivatives. The present invention relates to κ opioid receptor agonists comprising compounds or salts thereof having the chemical structure represented by the ge

Novel Calcium Antagonists. Synthesis and Structure-Activity Relationship Studies of Benzothiazoline Derivatives

A series of novel compounds having a benzothiazoline skeleton was studied for their structure-activity relationship (SAR) with respect to Ca2+ antagonist activity.As test compounds, analogues of 3-acyl-2-arylbenzothiazolines (3) were synthesize